The Effectiveness of YAG Iridotomy in Preventing Peripheral Anterior Synechia After CLASS in Prim… (NCT04912362) | Clinical Trial Compass
UnknownNot Applicable
The Effectiveness of YAG Iridotomy in Preventing Peripheral Anterior Synechia After CLASS in Primary Open Angle Glaucoma
China80 participantsStarted 2020-09-01
Plain-language summary
To investigate the effectiveness of YAG laser iridotomy in preventing peripheral anterior synechia after CO2 Laser-Assisted Sclerectomy Surgery and the long-term effect of reducing intraocular pressure
Who can participate
Age range18 Years – 50 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Primary open angle glaucoma patients in Ophthalmic Center;
* Topical use of hypotensive drugs in the treatment of poor or intolerable intraocular pressure control;
* The patients were 18 to 50 years old, regardless of gender;
* Class operation was performed;
* Patients are able and willing to comply with the research guidance and may complete all visits required by the research;
* Informed consent has been signed.
Exclusion Criteria:
* Allergic to any perioperative medication in this study;
* History of ocular trauma;
* Any previous intraocular surgery;
* Gonioscopy showed a narrow angle (Schaffer III or below);
* Secondary glaucoma was diagnosed;
* Optic atrophy caused by other reasons;
* Severe complications such as rupture of posterior capsule and choroidal hemorrhage occurred during operation;
* Patients with severe ocular complications after operation
* The patient's history indicated that he had severe dysfunction of heart, lung, liver and kidney;
* Women in pregnancy, lactation or planned pregnancy;
* The researchers believe that the patient's condition may put the patient at significant risk, may confuse the results of the study, or may significantly interfere with the patient's participation in the study.
What they're measuring
1
Intraocular pressure
Timeframe: 1 year
2
Peripheral anterior synechia
Timeframe: 1 year
Trial details
NCT IDNCT04912362
SponsorSecond Affiliated Hospital, School of Medicine, Zhejiang University